Hook & thesis
Celestica has been behaving like a highly cyclical, high-quality supply-chain business: earnings upside, upgraded guidance and then a short, sharp sell-off as investors reassess valuation. The tape has begun to correct that verdict. After a 53% year-over-year revenue jump in Q1 and a raised full-year guide to $19 billion, the stock has re-accelerated; today's move shows the market is starting to agree that Celestica is a primary beneficiary of hyperscaler and AI infrastructure spending. Importantly, Q2 results and related commentary - the natural next catalyst - are not yet fully priced into the current quote.
Why the market should care
Celestica is a global provider of electronics manufacturing and supply-chain solutions. Its two operating units - Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) - sit directly in the path of the data center, telecommunications and capital equipment spending that has been accelerating as hyperscalers expand AI infrastructure. Big-picture demand is obvious: hyperscalers and cloud providers are committing tens of billions to AI-related capex, and the supply chain for servers, optics, power and integration is where Celestica operates.
The fundamental driver
The core bull case is simple and numeric: Q1 revenue was $4.05 billion (up 53% YoY) and management moved FY2026 revenue guidance to $19 billion with adjusted EPS guidance to $10.15 - a material upgrade that signals stronger-than-expected demand across CCS/ATS. At today's market price the company sits with a market cap around $39.8 billion and reported trailing EPS in the $8.34 range (latest available), putting the stock in the ~40x earnings neighborhood. That valuation is high for a supplier, but it becomes harder to argue against it if revenue and margin expansion driven by hyperscaler capex continue into Q2 and beyond.
Supporting data points
- Recent operational proof: Q1 revenue $4.05B, beat consensus and prompted a guide raise to $19.0B for FY2026.
- Profitability: adjusted EPS printed $2.16 in Q1 and management's guide implies strong back-half contribution; trailing reported EPS sits near $8.34.
- Cash generation: free cash flow of approximately $491.5M - positive and meaningful for a capital-intensive supplier.
- Capital markets context: market cap about $39.8B and enterprise value roughly $39.44B, yielding EV/sales around 2.86x and EV/EBITDA ~28.5x today - premium multiples that require continued growth to justify.
- Technical picture: price recently traded through the 10-day SMA (~$335.25) and sits above the 9-day EMA (~$329.51), signaling short-term momentum. Volume has accelerated: today's volume topped 3.14M shares versus a two-week average near 1.82M.
Valuation framing
At roughly $39.8B market cap and a reported EPS level in the low-$8s, Celestica trades at a high absolute P/E (~40x on the latest reported EPS), and EV/EBITDA also sits at a premium. That multiple premium is only justified if growth persists and margins hold up against a ramp in server and storage assembly work. Consider the following qualitative frame: the company is transitioning from a mixed-recovery supplier to a primary integrator for AI infrastructure - a repositioning that can carry higher multiples. Quantitatively, management's guide to $19B revenue and $10.15 EPS for the full year implies materially higher forward EPS if delivered; in that scenario the multiple compresses. In short: today you pay for execution. If execution continues, current multiples can look reasonable; if demand softens, the premium will be quickly removed.
Catalysts (what gets the stock moving)
- Q2 results and guidance (expected in the coming reporting window): confirmation of accelerating CCS/server build work would be the immediate positive catalyst.
- Hyperscaler capex announcements or large AI infrastructure deals (several market pieces in June highlighted renewed hyperscaler spending) that translate into multi-quarter contract flow.
- Large customer wins or capacity expansion notices from Celestica that point to sustainable revenue beyond a single quarter.
- Upgrades from research shops after Q2 that re-rate the story from cyclical supplier to secular beneficiary of AI infrastructure.
Trade plan - actionable and disciplined
- Trade idea: Long Celestica (CLS) at an entry of $335.00.
- Stop loss: $310.00 (technical - below today's intraday low area and beneath the short-term consolidation band).
- Target: $420.00 (a mid-term re-rating toward the lower half of the 52-week range highs; represents upside if Q2 beats and guidance remains intact).
Horizon: mid term (45 trading days). I expect this trade to play out over the next 6-9 weeks: that timeline covers the Q2 reporting window, allows for post-earnings price discovery and gives time for re-rating if management confirms continued strength. If the company reports earlier than that, reassess intraday; if results are delayed, keep the stop in place and re-evaluate on any gap moves.
Position sizing & risk management
This is a trade-size idea, not an investment recommendation. With a $25.00 per-share downside from entry to stop, risk per share is defined; size the position so that loss if stopped out equals your planned risk allocation (for many retail accounts that will be 1-3% of portfolio value). Tight adherence to the stop is essential: the trade rewards discipline because the stock can gap sharply on headline risk.
Risks and counterarguments
- Cyclicality and pullbacks in hyperscaler spending. If hyperscalers pause or slow multi-quarter spend, demand for server assembly and optics could drop rapidly and margins compress. That would undermine the premium multiple.
- Valuation vulnerability. The stock trades at a high multiple (P/E in the ~40x area on latest EPS figures). Any slip versus guide or small miss on Q2 could trigger outsized multiple contraction.
- Execution risk. Rapid growth strains supply chain, labor and quality control. Misses in fulfillment or margin erosion would be punished quickly by the market.
- Concentration / customer risk. Large hyperscaler customers can exert pressure on pricing and terms; contract seasonality and timing can also create lumpy results.
- Counterargument: The re-rating is already baked in. A 53% YoY revenue jump and a raised $19B guide may have been fully priced into the stock already; today's rally could be a relief bounce that fades if Q2 merely matches expectations rather than materially exceeding them.
Why I'm still constructive, briefly
The market's reaction to Q1 was instructive: initially the stock fell despite a beat and guide raise, which signaled that some investors were focused on valuation and possible execution hiccups. Since then, the tape has steadied and volume has expanded on up-days. The near-term technical set-up - trading above the 10-day SMA and near the 9-day EMA - gives an asymmetric entry opportunity: you can buy nearer short-term support with a defined stop and a path to a re-rating if Q2 confirms the narrative. Short interest covers under ~2 days, which means a positive print could invite short-covering as an accelerator.
What would change my mind
I will get materially less constructive if any of the following occur: 1) Q2 results miss revenue or EPS expectations; 2) management withdraws the $19B revenue guide or cuts forward EPS guidance; 3) margin deterioration of more than a few hundred basis points driven by pricing pressure or execution failures. Conversely, a confirmed multi-quarter beat cadence and stronger-than-expected backlog disclosures would increase conviction and push me to take a longer-term position.
Conclusion
Celestica sits at an inflection: the company has shown revenue momentum and upgraded guidance, and hyperscaler AI capex trends create a clear runway. The market has started to price that in, but Q2 still contains upside risk/reward that isn't fully reflected at current levels. The proposed trade - long at $335 with a $310 stop and a $420 target over a mid-term (45 trading day) window - gives a defined risk posture while putting you in the name ahead of the next meaningful catalyst. Respect the stop and reassess post-earnings; the story is attractive if execution and hyperscaler demand hold, and quickly punitive if either disappoints.